🔎 Trials Near Me

ホーム › 骨髄増殖性腫瘍 › ワシントン

ワシントンにおける骨髄増殖性腫瘍の臨床試験

ワシントン内の拠点で、骨髄増殖性腫瘍に関する9件の研究が参加者を募集しています。

ワシントン内の都市

公式研究テキスト（英語）

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • Swedish Cancer Institute-Edmonds, Edmonds
  • Swedish Cancer Institute-Issaquah, Issaquah
  • Fred Hutchinson Cancer Center, Seattle
  • 他2件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05564390

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

  • University of Washington, Seattle
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT05320198

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

  • Swedish Cancer Institute-Edmonds, Edmonds
  • Swedish Cancer Institute-Issaquah, Issaquah
  • Swedish Medical Center-First Hill, Seattle
被験者募集中第2相
18歳〜59歳 · 全性別 · 2026/09/22更新 · NCT05554406

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT04282187

Project: Every Child for Younger Patients With Cancer

  • Seattle Children's Hospital, Seattle
  • Providence Sacred Heart Medical Center and Children's Hospital, Spokane
  • Mary Bridge Children's Hospital and Health Center, Tacoma
  • 他1件
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
被験者募集中第2相
6 Months – 65 Years · 全性別 · 2026/07/22更新 · NCT06013423

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

  • Fred Hutchinson Cancer Center, Seattle
被験者募集中第2相
18歳〜66歳 · 全性別 · 2026/03/17更新 · NCT06859424

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
被験者募集中第2相
1歳〜60歳 · 全性別 · 2026/03/12更新 · NCT03970096

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Seattle
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。